Redhill Biopharma Ltd (RDHL) — Cash Flow Quality Index
Redhill Biopharma Ltd (RDHL) has a Cash Flow Quality Index of -13.91x as of June 2023. Operating cash flow of $-10.59 Million is below net income of $761.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Redhill Biopharma Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Redhill Biopharma Ltd Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Redhill Biopharma Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Redhill Biopharma Ltd generate cash.
Annual Cash Flow Quality Index for Redhill Biopharma Ltd (2023–2023)
Year-by-year earnings quality comparison for Redhill Biopharma Ltd.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.50x | $-35.82 Million | $23.92 Million | — |